ArticleCancer management and research2023

CXCL12 and CXCR4 as Potential Early Biomarkers for Luminal A and Luminal B Subtypes of Breast Cancer.

Joanna Motyka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.